| #96 |
Ronald L. Verleg |
Stamicarbon B.V. |
2 |
| #96 |
Caroline Boon |
Solvay Pharmaceuticals, B.V. |
2 |
| #96 |
Belal Shadid |
Duphar International Research B.V. |
2 |
| #96 |
Gerrit A. Barf |
AbbVie |
2 |
| #96 |
Marinus W. Weststrate |
Duphar International Research B.V. |
2 |
| #96 |
Wilhelmus R. M. Overbeek |
Duphar International Research B.V. |
2 |
| #96 |
Eelco Klaver |
Oce-Technologies B.V. |
2 |
| #96 |
Jan W. Broenink |
Agilent Technologies |
2 |
| #96 |
Agnes ter Huurne |
American Cyanamid |
2 |
| #96 |
Henk Pluim |
Duphar International Research B.V. |
2 |
| #96 |
Nicolaas Buizer |
Duphar International Research B.V. |
2 |
| #96 |
Renee Van Yperen |
Degussa Ag |
2 |
| #96 |
Adriaan Kroon |
Agere Systems |
2 |
| #96 |
Jan G. Kraaijenbrink |
Duphar International Research B.V. |
2 |
| #96 |
Henry Wowick Dingley |
Moore Business Forms |
2 |
| #96 |
Willem Gaastra |
American Cyanamid |
2 |
| #96 |
Jurjen Frankena |
AbbVie |
2 |
| #96 |
Harmen Mons |
AbbVie |
2 |
| #96 |
Martinus J. Wanner |
Solvay Pharmaceuticals, B.V. |
2 |
| #96 |
Agatha A. M. Rensink |
Abbott |
2 |
| #96 |
Louis F. Pauli |
Duphar International Research B.V. |
2 |
| #96 |
Nico Van Wiltenburg |
Duphar International Research B.V. |
2 |
| #96 |
Jacobus Antonius Joseph den Hartog |
— |
2 |
| #96 |
Adrianus Van Den Hoogenband |
Solvay Pharmaceuticals, B.V. |
2 |
| #96 |
John Franciscus Zevenbergen |
Clearpak |
2 |
| #96 |
Menso P. Rappoldt |
Duphar International Research B.V. |
2 |
| #96 |
Cornelis W. Raven |
Duphar International Research B.V. |
2 |
| #96 |
Peter H. Van Amsterdam |
Duphar International Research B.V. |
2 |
| #96 |
Matthijs Alphons Rietveld |
— |
2 |
| #96 |
Hendrik Duinker |
Duphar International Research B.V. |
2 |
| #96 |
Peter H. H. Hermkens |
Duphar International Research B.V. |
2 |
| #96 |
Jan Zwagerman |
— |
2 |
| #133 |
Jules A. C. Elbers |
Duphar International Research B.V. |
1 |
| #133 |
Cornelis J. de Kluizenaar |
Duphar International Research B.V. |
1 |
| #133 |
Wybrand T. Loos |
Duphar International Research B.V. |
1 |
| #133 |
Jacob Jacobuw Louwerens |
American Cyanamid |
1 |
| #133 |
Aalzen de Haan |
Duphar International Research B.V. |
1 |
| #133 |
Hubertine E. M. Spijkers |
American Cyanamid |
1 |
| #133 |
Martijn Van Der Kraan |
— |
1 |
| #133 |
Livio Turcato |
Institut National Des Radioeléménts |
1 |
| #133 |
Jack A. J. den Hartog |
Solvay Pharmaceuticals, Gmbh |
1 |
| #133 |
Arnoldus Portengen |
Duphar International Research B.V. |
1 |
| #133 |
Bart Heijne |
Duphar International Research B.V. |
1 |
| #133 |
Leonarda C. Niemann |
Duphar International Research B.V. |
1 |
| #133 |
Lara Gonzalez Lopez |
— |
1 |
| #133 |
Hendrik W. Geluk |
Duphar International Research B.V. |
1 |
| #133 |
Jan-Willem van Lindenberg |
Cpm Europe B.V. |
1 |
| #133 |
Johannes Stolte |
Deutsche Thomson-Brandt Gmbh |
1 |
| #133 |
Monique E. A. De Bruin-Van Der Flier |
Duphar International Research B.V. |
1 |
| #133 |
Gerrit J. Lagerweij |
Duphar International Research B.V. |
1 |